v3.25.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Gain (Loss), Net [Member]
Accumulated Deficit [Member]
Beginning balance at Dec. 31, 2023 $ 230,760 $ 10 $ 362,004 $ 49 $ (131,303)
Beginning balance, shares at Dec. 31, 2023   96,414,963      
Exercise of common stock options, shares issued under the employee stock purchase plan, and release of restricted stock units 258   258    
Exercise of common stock options and release of restricted stock units, Shares   159,086      
Stock-based compensation 3,315   3,315    
Net loss and comprehensive loss (10,465)     (173) (10,292)
Ending balance at Mar. 31, 2024 223,868 $ 10 365,577 (124) (141,595)
Ending balance, shares at Mar. 31, 2024   96,574,049      
Beginning balance at Dec. 31, 2023 230,760 $ 10 362,004 49 (131,303)
Beginning balance, shares at Dec. 31, 2023   96,414,963      
Net loss and comprehensive loss (23,002)        
Ending balance at Jun. 30, 2024 215,241 $ 10 369,487 (145) (154,111)
Ending balance, shares at Jun. 30, 2024   96,939,797      
Beginning balance at Mar. 31, 2024 223,868 $ 10 365,577 (124) (141,595)
Beginning balance, shares at Mar. 31, 2024   96,574,049      
Exercise of common stock options, shares issued under the employee stock purchase plan, and release of restricted stock units 545   545    
Exercise of common stock options, shares issued under the employee stock purchase plan, and release of restricted stock units, Shares   365,748      
Stock-based compensation 3,365   3,365    
Net loss and comprehensive loss (12,537)     (21) (12,516)
Ending balance at Jun. 30, 2024 215,241 $ 10 369,487 (145) (154,111)
Ending balance, shares at Jun. 30, 2024   96,939,797      
Beginning balance at Dec. 31, 2024 $ 256,798 $ 10 379,873 220 (123,305)
Beginning balance, shares at Dec. 31, 2024 97,954,172 97,954,172      
Exercise of common stock options, shares issued under the employee stock purchase plan, and release of restricted stock units $ 725   725    
Exercise of common stock options and release of restricted stock units, Shares   175,632      
Stock-based compensation 5,539   5,539    
Net loss and comprehensive loss (34,088)     (148) (33,940)
Ending balance at Mar. 31, 2025 228,974 $ 10 386,137 72 (157,245)
Ending balance, shares at Mar. 31, 2025   98,129,804      
Beginning balance at Dec. 31, 2024 $ 256,798 $ 10 379,873 220 (123,305)
Beginning balance, shares at Dec. 31, 2024 97,954,172 97,954,172      
Net loss and comprehensive loss $ (79,089)        
Ending balance at Jun. 30, 2025 $ 192,321 $ 10 394,485 (46) (202,128)
Ending balance, shares at Jun. 30, 2025 98,697,658 98,697,658      
Beginning balance at Mar. 31, 2025 $ 228,974 $ 10 386,137 72 (157,245)
Beginning balance, shares at Mar. 31, 2025   98,129,804      
Exercise of common stock options, shares issued under the employee stock purchase plan, and release of restricted stock units 2,697   2,697    
Exercise of common stock options, shares issued under the employee stock purchase plan, and release of restricted stock units, Shares   567,854      
Stock-based compensation 5,651   5,651    
Net loss and comprehensive loss (45,001)     (118) (44,883)
Ending balance at Jun. 30, 2025 $ 192,321 $ 10 $ 394,485 $ (46) $ (202,128)
Ending balance, shares at Jun. 30, 2025 98,697,658 98,697,658